Antitrust · Preliminary Approval Sought

Intuitive Surgical Agrees to $450M Settlement of Hospitals’ da Vinci Robot Antitrust Class Action

Published November 21, 2026

About 2,200 hospitals and surgery centers that bought da Vinci robot service and EndoWrist instruments from Intuitive Surgical between 2017 and 2021 would share $450 million under a settlement filed for court approval in November 2026. Patients are not part of the class, and claims are not open yet.

Surgeon in a mask and cap in an operating room

What Is This About?

Intuitive Surgical, Inc., which makes the da Vinci surgical robot, has agreed to pay $450 million to settle an antitrust class action brought by hospitals. On November 20, 2026, the hospitals asked the U.S. District Court for the Northern District of California to preliminarily approve the deal in In re Da Vinci Surgical Robot Antitrust Litigation, No. 4:21-cv-03825-AMO. The motion is set for a hearing on April 1, 2027 before U.S. District Judge Araceli Martínez-Olguín in Oakland.

Besides the cash, Intuitive agreed to five years of changes meant to open up competition in refurbishing EndoWrist instruments and servicing da Vinci robots. The hospitals’ economics expert values those changes at about $1.06 billion to $1.93 billion. The settlement was signed October 16, 2026, after a two-day mediation, and still needs the court’s approval.

Status Preliminary Approval Requested Motion filed Nov. 20, 2026 · hearing April 1, 2027
Settlement $450 million cash + 5 years of structural relief Split pro rata by EndoWrist and da Vinci service purchases · no money reverts to Intuitive
Can I Claim? Hospitals only — claims not open Patients and surgeons are not class members

Who Is in the Class

The court certified the class on March 31, 2025. It covers all entities that bought EndoWrist instruments and da Vinci service from Intuitive in the United States from May 21, 2017 through December 31, 2021, except hospitals run by the Departments of Defense and Veterans Affairs. That is about 2,200 hospitals and surgery centers. Three hospital systems opted out after class notice went out in early 2026, and the settlement does not propose a second chance to opt out.

Patients who had robotic surgery are not in the class, and the case does not involve claims that the robot injured anyone. The settlement expressly leaves out unrelated product-liability and personal-injury claims.

What the Lawsuit Claimed

The hospitals sued in 2021 under Sections 1 and 2 of the Sherman Act. They claimed Intuitive used tying, exclusive dealing and monopolization to control the markets for da Vinci service and for EndoWrist repair and replacement. That included use-count limits on EndoWrist instruments and contract terms discouraging hospitals from using refurbished instruments or outside service companies. Intuitive disputed the claims and argued its limits reflected engineering and patient-safety concerns. No court has found Intuitive liable.

The case was headed for trial. The court denied Intuitive’s motion to dismiss in January 2022, ruled at summary judgment in March 2024 that the da Vinci robot and EndoWrists are separate products, and certified the class in 2025. The Ninth Circuit declined to hear Intuitive’s appeal of class certification.

What the Settlement Provides

Intuitive would pay $450 million into an interest-bearing fund within 30 days of preliminary approval. For five years after the settlement takes effect, it also agreed to:

Intuitive can still promote its own products, offer lawful pricing and make genuine product improvements. In exchange, class members would release claims tied to the conduct in the case, including related claims that arise during the five-year period.

How the Money Would Be Divided

After court-approved fees and costs, the fund would be paid pro rata to eligible class members that file valid claims, based on the plaintiffs’ expert’s damages calculation for each member’s EndoWrist and da Vinci service purchases. A.B. Data, the proposed claims administrator, would send claim forms pre-filled with each member’s purchase data from Intuitive’s records where possible, with a unique ID for filing online. Claims could also be mailed. Members that disagree with their data could submit records. Payments would go out by wire transfer or check. Any money left after distribution would go to a court-approved charitable recipient, not back to Intuitive.

Class counsel plan to ask for up to one-third of the fund in attorneys’ fees and up to $10 million in expenses, plus $100,000 service awards for each of the three hospital plaintiffs. The court decides those amounts after class members can object.

The motion compares the fund with the damages estimates in the case. The plaintiffs’ expert put single damages through 2023 at roughly $1.28 billion to $3.46 billion across EndoWrists and service, so the fund is about 13% to 35% of that range. Intuitive’s expert calculated about $420 million.

What Happens Next

The court will consider preliminary approval at the April 1, 2027 hearing. Under the proposed schedule, notice and the claims period would begin 30 days after a preliminary approval order. Objections would be due 80 days after the order, and the final approval hearing would come at least 130 days after it. Class members would get notice by email and mail, and details will be posted on the official case website.

Questions

Can patients who had da Vinci robotic surgery get money from this settlement?

No. The class is made up of hospitals, surgery centers and other entities that bought EndoWrist instruments and da Vinci service directly from Intuitive in the U.S. from May 21, 2017 through December 31, 2021. Patients and surgeons are not class members, and the case is not about injuries from surgery.

How would the $450 million da Vinci settlement be divided?

After court-approved attorneys' fees, expenses and service awards, the fund would be split pro rata among eligible class members that file valid claims, based on the plaintiffs' expert's damages calculation for each member's EndoWrist and da Vinci service purchases. Claim forms would be pre-filled with purchase data from Intuitive's records where possible. No money would return to Intuitive.

What changes would Intuitive make under the da Vinci settlement?

For five years after the settlement takes effect, Intuitive would let customers use FDA-cleared third-party remanufactured EndoWrists without losing service or warranty coverage, keep an authorization process for refurbishing and resetting the use counters of eligible EndoWrists, not block qualifying third-party refurbishers, and pilot a program letting trained hospital technicians and independent service companies maintain and repair da Vinci X and Xi robots, with the pilot projected to launch in early 2028.

When will the da Vinci settlement be approved?

The motion for preliminary approval is set for a hearing on April 1, 2027. If the court grants it, notice and the claims period would start about 30 days later, and a final approval hearing would follow at least 130 days after the preliminary approval order.

Sources

For more class actions keep scrolling below.
Status Preliminary approval requested · hearing April 1, 2027
Case Title In re Da Vinci Surgical Robot Antitrust Litigation
Case Number 4:21-cv-03825-AMO
Court U.S. District Court, Northern District of California (Oakland)
Settlement $450 million + structural relief
Class Period May 21, 2017 – December 31, 2021

More Antitrust News